Establishment Labs Holdings (ESTA) Total Non-Current Liabilities (2017 - 2026)
Establishment Labs Holdings' (ESTA) quarterly Total Non-Current Liabilities came in at $334.2 million in Q1 2026, up 13.97% year-on-year from $293.2 million in Q1 2025, and up 0.5% quarter-over-quarter from $332.5 million in Q4 2025.
Establishment Labs Holdings (ESTA) Total Non-Current Liabilities (2017 - 2026) Analysis & Trends
Establishment Labs Holdings' Total Non-Current Liabilities history runs 10 years deep, the most recent figure standing at $334.2 million for Q1 2026.
- On a quarterly basis, Total Non-Current Liabilities rose 13.97% year-over-year to $334.2 million in Q1 2026; TTM through Mar 2026 was $334.2 million, a 13.97% increase from a year earlier, with the FY2025 full-year figure at $332.5 million, up 13.84% from the prior year.
- Total Non-Current Liabilities climbed to $334.2 million in Q1 2026 per ESTA's latest filing, from $332.5 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $334.2 million in Q1 2026 and bottomed at $91.9 million in Q1 2022.
- The 5-year median for Total Non-Current Liabilities is $243.4 million (2024), against an average of $248.7 million.
- Across the five-year window, Total Non-Current Liabilities surged 151.88% in 2022 and grew 4.25% in 2024, its largest moves.
- Year by year, Total Non-Current Liabilities stood at $217.6 million in 2022, then advanced by 14.24% to $248.6 million in 2023, then gained by 17.48% to $292.1 million in 2024, then gained by 13.84% to $332.5 million in 2025, then rose by 0.5% to $334.2 million in 2026.
- Per Business Quant, the three latest ESTA Total Non-Current Liabilities figures stand at $334.2 million (Q1 2026), $332.5 million (Q4 2025), and $321.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 41.44 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 41.88 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.64 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.53 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.85 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.57 Bn |
| 10 | Establishment Labs Holdings | 2.73 Bn | 2.66 Bn | 42.34 Mn | 334.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 334.15 Mn |
| Dec 31, 2025 | 332.48 Mn |
| Sep 30, 2025 | 321.42 Mn |
| Jun 30, 2025 | 305.24 Mn |
| Mar 31, 2025 | 293.18 Mn |
| Dec 31, 2024 | 292.06 Mn |
| Sep 30, 2024 | 248.68 Mn |
| Jun 30, 2024 | 238.61 Mn |
| Mar 31, 2024 | 243.38 Mn |
| Dec 31, 2023 | 248.60 Mn |
| Sep 30, 2023 | 238.54 Mn |
| Jun 30, 2023 | 228.43 Mn |
| Mar 31, 2023 | 223.53 Mn |
| Dec 31, 2022 | 217.62 Mn |
| Sep 30, 2022 | 186.13 Mn |
| Jun 30, 2022 | 184.02 Mn |
| Mar 31, 2022 | 91.90 Mn |
| Dec 31, 2021 | 86.40 Mn |
| Sep 30, 2021 | 84.65 Mn |
| Jun 30, 2021 | 81.07 Mn |